TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 3 | 1 | 3 | 3 | 1 | 10 | 15 | 27 | 36 | 15 |
| P | %wins | 100 | 67 | 67 | 100 | 100 | 100 | 89 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/1/20 21:44 | 8/31/20 | BMRN | Biomarin Pharmaceutical Inc | DE | Health | Drug | Pharmaceutical Preparations | Pyott David E I | CA | D | P | 1,002 | 78.26 | 0 | 13 | 71 | 31 | D | |||||||||||||||
10/14/16 16:22 | 10/13/16 | ALNY | Alnylam Pharmaceuticals, Inc. | Health | Drug | Pharmaceutical Preparations | Pyott David E I | MA | D | P | 1,032 | 37.00 | 33 | 28 | New | 28 | I | -56 | -54 | -47 | -44 | -48 | -52 | -47 | 2 | 4 | 6 | 31 | 17 | 43 | |||
5/1/13 17:29 | 5/1/13 | EW | Edwards Lifesciences Corp | DE | Health | Orthop | Orthopedic, Prosthetic & Surg | Pyott David E I | CA | D | P | 189 | 62.95 | 33 | 3 | 7 | 48 | D | -24 | -22 | -26 | -29 | -19 | -23 | -23 | -2 | 3 | 2 | 4 | 13 | 17 | 30 | |
11/6/08 17:14 | 11/6/08 | AGN | Allergan Inc | DE | Health | Drug | Pharmaceutical Preparations | Pyott David E I | CA | DO | CB,CEO | P | 959 | 38.35 | 33 | 25 | 19 | 157 | I | -5 | -17 | -12 | -12 | -14 | 12 | 11 | -5 | 1 | -6 | -4 | 15 | 22 | 41 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |